Quick Answer
CareDx, Inc. reported Research And Development Expense of $71.43 million for the year ending 2025.
- CareDx, Inc. showed a decrease of -1.5% in Research And Development Expense from 2024 to 2025.
- This data is from CareDx, Inc.'s annual report (Form 10-K), filed with the SEC on February 25, 2026.
- XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2013: $846.0 thousand | Q3 2013: $668.0 thousand | Q1 2014: $720.0 thousand | Q2 2014: $792.0 thousand | Q3 2014: $1.04 million | Q1 2015: $1.42 million | Q2 2015: $2.51 million | Q3 2015: $2.70 million | Q1 2016: $3.16 million | Q2 2016: $3.14 million | Q3 2016: $2.93 million | Q1 2017: $3.28 million | Q2 2017: $3.12 million | Q3 2017: $2.96 million | Q1 2018: $3.37 million | Q2 2018: $3.50 million | Q3 2018: $3.87 million | Q1 2019: $5.61 million | Q2 2019: $7.63 million | Q3 2019: $8.52 million | Q1 2020: $10.01 million | Q2 2020: $13.13 million | Q3 2020: $12.47 million | Q1 2021: $16.00 million | Q2 2021: $19.04 million | Q3 2021: $19.44 million | Q1 2022: $21.88 million | Q2 2022: $22.63 million | Q3 2022: $22.31 million | Q1 2023: $24.36 million | Q2 2023: $20.23 million | Q3 2023: $19.00 million | Q1 2024: $18.71 million | Q2 2024: $19.69 million | Q3 2024: $17.49 million | Q1 2025: $18.52 million | Q2 2025: $16.83 million | Q3 2025: $16.77 million.
- Over the full 14 years of available data (2012 to 2025), CareDx, Inc.'s Research And Development Expense has grown by 1,403.1%.
- Historical annual values: Fiscal year 2025: $71.43 million | Fiscal year 2024: $72.51 million | Fiscal year 2023: $82.42 million | Fiscal year 2022: $90.39 million | Fiscal year 2021: $76.53 million | Fiscal year 2020: $48.94 million | Fiscal year 2019: $30.71 million | Fiscal year 2018: $14.51 million | Fiscal year 2017: $12.39 million | Fiscal year 2016: $12.39 million | Fiscal year 2015: $9.33 million | Fiscal year 2014: $3.85 million | Fiscal year 2013: $3.18 million | Fiscal year 2012: $4.75 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: